Intercept Pharmaceuticals Inc (ICPT)
29.46
+1.38 +4.91%
NASDAQ
Jan 22, 20:00
USD
Intercept Pharmaceuticals Key Stats
Stock Price Performance
1 Month Price Returns (Daily) | Upgrade |
3 Month Price Returns (Daily) | Upgrade |
6 Month Price Returns (Daily) | Upgrade |
Year to Date Price Returns (Daily) | Upgrade |
1 Year Price Returns (Daily) | Upgrade |
3 Year Price Returns (Daily) | Upgrade |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
52-Week High Date | Jan. 24, 2020 |
52-Week Low Date | Jan. 04, 2021 |
Dividends and Shares
Shares Outstanding | 32.99M |
Dividend | -- |
Dividend Yield (Forward) | Upgrade |
Dividend Yield | 0.00% |
Cash Dividend Payout Ratio | Upgrade |
Payout Ratio | Upgrade |
Latest Dividend Pay Date | -- |
Next Ex-Dividend Date | -- |
Last Split Factor | -- |
Last Split Date | -- |
Risk Metrics
Estimates
Income Statement
Balance Sheet
Cash Flow Statement
Cash from Financing (TTM) | 5.343M |
Cash from Investing (TTM) | 198.86M |
Cash from Operations (TTM) | -214.54M |
Capital Expenditures (TTM) | Upgrade |
Common Size Statements
Net Income (% of Quarterly Revenues) | Upgrade |
Net Income (% of Annual Revenues) | Upgrade |
Earnings Quality
Accruals (Quarterly) | Upgrade |
Beneish M-Score (Annual) | Upgrade |
Profitability
Gross Profit Margin (Quarterly) | 97.70% |
Profit Margin (Quarterly) | -83.59% |
EBITDA Margin (TTM) | Upgrade |
Operating Margin (TTM) | Upgrade |
Management Effectiveness
Current Valuation
Liquidity and Solvency
Employee Count Metrics
Total Employees (Annual) | Upgrade |
Revenue Per Employee (Annual) | Upgrade |
Net Income Per Employee (Annual) | Upgrade |